Report overview
The global OTC Topical Antifungals market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Azoles
Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of OTC Topical Antifungals include Novartis AG, Merck KGaA, Dr. Reddy?s Laboratories Ltd., Pfizer, Inc., Abbott Laboratories, Bayer AG, Sanofi and Crown, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
OTC topical antifungals are over-the-counter medications that are used to treat fungal infections on the skin. This includes creams, lotions, powders, sprays, and other topical formulations that contain antifungal agents.
This report aims to provide a comprehensive presentation of the global market for OTC Topical Antifungals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Topical Antifungals. This report contains market size and forecasts of OTC Topical Antifungals in global, including the following market information:
Global OTC Topical Antifungals Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global OTC Topical Antifungals Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five OTC Topical Antifungals companies in 2023 (%)
We surveyed the OTC Topical Antifungals manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global OTC Topical Antifungals Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global OTC Topical Antifungals Market Segment Percentages, by Type, 2023 (%)
Azoles
Allylamine
Tolnaftate
Undecylenic Acid
Others
Global OTC Topical Antifungals Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global OTC Topical Antifungals Market Segment Percentages, by Application, 2023 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global OTC Topical Antifungals Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global OTC Topical Antifungals Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies OTC Topical Antifungals revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies OTC Topical Antifungals revenues share in global market, 2023 (%)
Key companies OTC Topical Antifungals sales in global market, 2019-2024 (Estimated), (K Units)
Key companies OTC Topical Antifungals sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Merck KGaA
Dr. Reddy?s Laboratories Ltd.
Pfizer, Inc.
Abbott Laboratories
Bayer AG
Sanofi
Crown
Outline of Major Chapters:
Chapter 1: Introduces the definition of OTC Topical Antifungals, market overview.
Chapter 2: Global OTC Topical Antifungals market size in revenue and volume.
Chapter 3: Detailed analysis of OTC Topical Antifungals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of OTC Topical Antifungals in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global OTC Topical Antifungals capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
